Ancillare, LP, a global clinical and ancillary supply chain provider for pharma and biopharma, as well as contract and medical research organizations, was granted a Wholesale Distribution Authorization (WDA) for Human use by the United Kingdom Medicines and Healthcare Products Regulatory Agency (MHRA). This will allow Ancillare to continue to support study sponsors’ European needs, regardless of uncertainty about Brexit’s impact on pharmaceutical supply chains. The licensure is c...